GB0513058D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0513058D0
GB0513058D0 GBGB0513058.8A GB0513058A GB0513058D0 GB 0513058 D0 GB0513058 D0 GB 0513058D0 GB 0513058 A GB0513058 A GB 0513058A GB 0513058 D0 GB0513058 D0 GB 0513058D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
acid
pleuromutilin
dichlorophenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0513058.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GBGB0513058.8A priority Critical patent/GB0513058D0/en
Publication of GB0513058D0 publication Critical patent/GB0513058D0/en
Priority to AT06752578T priority patent/ATE519737T1/de
Priority to PCT/AT2006/000242 priority patent/WO2007000001A2/en
Priority to US11/993,813 priority patent/US20100160266A1/en
Priority to EP06752578A priority patent/EP1896405B1/en
Priority to JP2008518553A priority patent/JP2008546809A/ja
Priority to TW095122515A priority patent/TW200730487A/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/95—Spiro compounds containing "not free" spiro atoms
    • C07C2603/98—Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members
    • C07C2603/99—Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members containing eight-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GBGB0513058.8A 2005-06-27 2005-06-27 Organic compounds Ceased GB0513058D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0513058.8A GB0513058D0 (en) 2005-06-27 2005-06-27 Organic compounds
AT06752578T ATE519737T1 (de) 2005-06-27 2006-06-14 Organische verbindungen
PCT/AT2006/000242 WO2007000001A2 (en) 2005-06-27 2006-06-14 Pleuromutilin salts with salicylic acid, azelaic acid, sebacic acid and diclofenac
US11/993,813 US20100160266A1 (en) 2005-06-27 2006-06-14 Organic compounds
EP06752578A EP1896405B1 (en) 2005-06-27 2006-06-14 Organic compounds
JP2008518553A JP2008546809A (ja) 2005-06-27 2006-06-14 有機化合物
TW095122515A TW200730487A (en) 2005-06-27 2006-06-22 Organic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0513058.8A GB0513058D0 (en) 2005-06-27 2005-06-27 Organic compounds

Publications (1)

Publication Number Publication Date
GB0513058D0 true GB0513058D0 (en) 2005-08-03

Family

ID=34856202

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0513058.8A Ceased GB0513058D0 (en) 2005-06-27 2005-06-27 Organic compounds

Country Status (7)

Country Link
US (1) US20100160266A1 (enExample)
EP (1) EP1896405B1 (enExample)
JP (1) JP2008546809A (enExample)
AT (1) ATE519737T1 (enExample)
GB (1) GB0513058D0 (enExample)
TW (1) TW200730487A (enExample)
WO (1) WO2007000001A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7574259B1 (en) 2004-11-12 2009-08-11 Pacesetter, Inc. Capture threshold and lead condition analysis
EP1808431A1 (en) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
JP4905182B2 (ja) 2007-03-01 2012-03-28 トヨタ自動車株式会社 燃料電池システム
EP1972618A1 (en) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
FR2953493B1 (fr) 2009-12-08 2012-01-27 Eurocopter France Aeronef muni d'un dispositif d'aide au pilotage lorsqu'il porte une charge externe avec une elingue, et procede mis en oeuvre par ledit dispositif
US9622848B2 (en) 2011-02-23 2017-04-18 Boston Scientific Scimed, Inc. Urethral stent system and method
US8728240B2 (en) * 2012-05-02 2014-05-20 Msp Corporation Apparatus for vapor condensation and recovery
EP3008129A1 (de) 2013-06-14 2016-04-20 Basf Se Beheizbare formkörper aus elektrisch leitfähigem thermoplastischem polyurethan
JP6715772B2 (ja) 2014-01-22 2020-07-01 ナブリヴァ セラピュティクス ゲーエムベーハー １２−ｅｐｉ−プロイロムチリン
DE102014115846A1 (de) 2014-10-30 2016-05-04 Maxitex Gmbh Vorrichtung mit heizbarer Flächen von homogener Wärmeverteilung
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN110054629A (zh) * 2019-03-27 2019-07-26 广东萱嘉医品健康科技有限公司 一种杜鹃花酸生物碱离子盐及其制备方法与应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US516526A (en) * 1894-03-13 Machine for making check-row wire
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
US3987184A (en) * 1974-06-07 1976-10-19 Glyco Chemicals, Inc. Dimethylol dimethylhydantoin solution
US3987194A (en) * 1975-05-12 1976-10-19 E. R. Squibb & Sons, Inc. Use of pleuromutilin derivatives for the treatment of swine dysentery
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4713394A (en) * 1986-01-17 1987-12-15 Thornfeldt Carl R Treatment of nonacne inflammatory and infectious dermatoses and hair loss
IE913655A1 (en) * 1990-11-06 1992-05-22 Zeneca Ltd Synergistic agents
JPH05221857A (ja) * 1992-02-14 1993-08-31 Arakusu:Kk 配合解熱鎮痛剤
JP3326023B2 (ja) * 1994-10-13 2002-09-17 花王株式会社 皮膚化粧料
JP3745439B2 (ja) * 1995-07-06 2006-02-15 花王株式会社 皮膚外用剤
JPH1095773A (ja) * 1996-09-19 1998-04-14 Inui Kk 抗菌活性を有するビス第四アンモニウム塩化合物及びその製造方法
UY25225A1 (es) * 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
JP2000095763A (ja) * 1998-09-18 2000-04-04 Inui Kk 抗菌活性を有するビス第四アンモニウム塩化合物
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
JP2002284697A (ja) * 2001-01-16 2002-10-03 Kanebo Ltd 皮膚外用剤
JP3482473B2 (ja) * 2001-03-23 2003-12-22 寛紀 高麗 ビス型第４アンモニウム塩化合物及びその製造法
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
DK1633374T3 (da) * 2003-06-10 2007-12-03 Intendis Gmbh Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof
CA2533421A1 (en) * 2003-07-23 2005-02-03 Xoma Technology Ltd. Use of xmp-629 for the treatment of acne
US7875630B2 (en) * 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use

Also Published As

Publication number Publication date
ATE519737T1 (de) 2011-08-15
EP1896405B1 (en) 2011-08-10
WO2007000001A2 (en) 2007-01-04
JP2008546809A (ja) 2008-12-25
EP1896405A2 (en) 2008-03-12
WO2007000001A3 (en) 2007-03-08
TW200730487A (en) 2007-08-16
US20100160266A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
FIC20253005I1 (fi) Seladelpaarin L-lysiinisuola, erityisesti seladelpaari-L-lysiinidihydraatti
GB0513058D0 (en) Organic compounds
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
NZ593050A (en) Glucagon-like-peptide-2 (glp-2) analogues
IN2012DN02610A (enExample)
DE602005010109D1 (de) 1,1a,5,5a-tetrahydro-3-thia-cyclopropaäaüpentaleneptor-agonisten
IL185108A0 (en) Processes for preparing cinacalcet hydrochloride crystal form i
EP1885630A4 (en) CHAIN DRIVEN ROBOT ARM
CR10157A (es) Compuestos químicos
HRP20120323T1 (en) Diarylhydantoin compounds
ZA200800371B (en) Method for prolonging the life o animals
IL184120A0 (en) 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl-esters
DK1499577T3 (da) 2-(2,6-dichlorphenyl)-diarylimidazoler
CY1106579T1 (el) Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης
GEP20105033B (en) Therapeutic agent for diabetes
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
RU2002107079A (ru) Вещество, обладающее седативным действием
AP2005003393A0 (en) 3-(1-Ä3-(1,3-benzothiazol-6-yl) ropylcarbamoylÜcycloalkyl) propanoic acid derivatives as NEP inhibitors.
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
DE50303218D1 (de) Kastenförmiger behälter für flache sendungen
DE50208368D1 (de) Rinnenschuss für strebförderer mit laderampe
RU2002123417A (ru) Кормовая добавка для сельскохозяйственной птицы
BRPI0605918A2 (pt) rosuvastatina cálcica com um baixo conteúdo de sal
TW200621756A (en) Method for manufacturing enantiomeric imidazole compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)